Masciullo V, Khalili K, Giordano A
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Jefferson Alumni Hall Room 226, Philadelphia, PA 19107, USA.
Int J Oncol. 2000 Nov;17(5):897-902. doi: 10.3892/ijo.17.5.897.
The retinoblastoma gene family is composed of three members: the product of the retinoblastoma gene (pRb), which is one of the most well studied tumor suppressor genes and two related proteins, pRb2/p130 and p107, which have been shown to be structurally and functionally similar to pRb. The three retinoblastoma family members show growth suppressive properties, although the growth arrest mediated by each of the three pocket regions of the proteins is not identical. This supports the idea that although the three members may complement each other, they are not fully functional or redundant. Among the three family members, the retinoblastoma-related gene product pRb2/p130 is a tumor suppressor gene and an effective candidate target for gene therapy approach. The aim of this review is to examine the role of the Rb family members in growth regulation discussing their putative prognostic and therapeutical impact in human cancer.
视网膜母细胞瘤基因(pRb)的产物,它是研究最为深入的肿瘤抑制基因之一;以及另外两个相关蛋白pRb2/p130和p107,它们在结构和功能上与pRb相似。视网膜母细胞瘤家族的这三个成员均具有生长抑制特性,尽管由这三种蛋白质的每个口袋区域介导的生长停滞并不相同。这支持了这样一种观点,即虽然这三个成员可能相互补充,但它们并非完全功能相同或冗余。在这三个家族成员中,视网膜母细胞瘤相关基因产物pRb2/p130是一种肿瘤抑制基因,也是基因治疗方法的有效候选靶点。本综述的目的是探讨Rb家族成员在生长调节中的作用,并讨论它们在人类癌症中可能的预后和治疗影响。